Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.

Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999 Jul; 180(1):61-7.

View in: PubMed

subject areas

Acquired Immunodeficiency Syndrome
Adult
Antigens, CD
Double-Blind Method
Esophageal Diseases
Female
HIV Infections
Humans
Male
Placebos
Quality of Life
Receptors, Tumor Necrosis Factor
Receptors, Tumor Necrosis Factor, Type II
Stomatitis, Aphthous
Thalidomide
Tumor Necrosis Factor-alpha
Ulcer
United States

authors with profiles

Beverly Sha